Invention Grant
- Patent Title: Aminoazole derivative
-
Application No.: US16060701Application Date: 2016-12-09
-
Publication No.: US10689354B2Publication Date: 2020-06-23
- Inventor: Shinnosuke Hosoda , Gen Unoki , Hidekazu Watanabe , Kosuke Sasaki , Jun Shibata , Emi Yokoyama , Kyohei Horie , Kenichiro Takagi
- Applicant: Teijin Pharma Limited
- Applicant Address: JP Chiyoda-ku, Tokyo
- Assignee: Teijin Pharma Limited
- Current Assignee: Teijin Pharma Limited
- Current Assignee Address: JP Chiyoda-ku, Tokyo
- Agency: Sughrue Mion, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3894ea12
- International Application: PCT/JP2016/086784 WO 20161209
- International Announcement: WO2017/099237 WO 20170615
- Main IPC: C07D263/48
- IPC: C07D263/48 ; C07C335/12 ; A61K31/421 ; A61P5/26 ; C07D277/56 ; C07C335/18 ; C07D249/08 ; C07D417/12 ; A61K31/4725 ; A61K31/498 ; A61K31/428 ; A61K31/426 ; A61K31/497 ; A61K31/427 ; A61K31/4439 ; A61K31/454 ; A61K31/4709 ; A61K31/4245 ; C07D413/12 ; A61K31/422 ; C07D277/82 ; A61K31/501 ; A61K31/433 ; A61K31/5377

Abstract:
A compound, represented by the following formula or a medically acceptable salt thereof, having an effect of regulating the activity of an androgen receptor. In the formula, X represents S, O; Z represents (Ra)n-A-(CR13R14)0-1—(CR11R12)0-1; A represents aryl, heteroaryl; R1 represents alkyl, cycloalkyl, alkenyl, alkynyl, alkoxyalkyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl; R2 represents hydrogen, halogen, alkyl, cycloalkyl, phenyl; R3 represents hydrogen, halogen, alkyl, cycloalkyl, alkoxyalkyl, alkenyl, alkynyl, cycloalkenyl, aryl, arylalkyl, heterocycle, heterocyclic alkyl, acyl, cycloalkylcarbonyl, benzoyl, spiroalkyl, adamantyl, silyl, R31R32NCO—; R4 and R5 represent hydrogen, halogen, alkyl, phenyl, and cycloalkyl.
Public/Granted literature
- US20190031628A1 AMINOAZOLE DERIVATIVE Public/Granted day:2019-01-31
Information query